Treatment with cannabidiol led to improved seizure and nonseizure outcomes in patients with various forms of epilepsy, data show. The BECOME-TSC study evaluated outcomes of Epidiolex (Jazz ...

Massachusett-based Stoke Therapeutics STOK is making rapid progress with the development of zorevunersen (STK-001), its investigational candidate for treating Dravet syndrome, a severe and progressive ...

Three blockbuster-potential assets in late-stage clinical trials and four pivotal readouts expected in 2025; anticipate four commercial assets by ...

and generalized epilepsy, and the POWER1 study in FOS. We are also thrilled to have received a third rare pediatric drug designation (RPDD) for relutrigine in Dravet Syndrome, and with strong interest ...

LOS ANGELES — A wearable, behind-the-ear EEG device is feasible for assessment of sleep patterns in young people with Dravet syndrome, according to a poster presented at the American Epilepsy ...

“What families and we as clinicians now want are medicines that go beyond reducing seizures to address the neurodevelopmental issues associated with Dravet syndrome, including giving patients ...

Pirates from across the country attended the funeral of a 14-year-old fan of all things swashbuckling. Billy Maskell, from ...

Veronica Court and Austin Rivera, a couple living in Oakwood, lost their 13-month-old daughter, Violeta, in November due to a rare genetic disorder, after which they spent weeks trying to get coverage ...

A Wigan woman took part in six punishing work-out challenges during her gym’s 12-hour fund-raiser to raise money for charity.

Bexicaserin is being developed to treat a group of disorders known as developmental and epileptic encephalopathies (DEEs), including Dravet syndrome ... reduced seizure frequency by more than ...